Cargando…
Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) play a crucial role in cancer treatment, particularly in breast cancer, and their mechanism of drug resistance is a topic of global interest in research. Hence, it is vital to comprehend the distinctions between various CDK4/6i, including their mechan...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354263/ https://www.ncbi.nlm.nih.gov/pubmed/37475713 http://dx.doi.org/10.3389/fphar.2023.1212986 |